We are live on ! Find out more
SLXP

SALIX PHARMACEUTICALS LTD DEL
SLXP

Delisted

SLXP was delisted on the 31st of March, 2015.

Back to rankings

243 hedge funds and large institutions have $3.96B invested in SALIX PHARMACEUTICALS LTD DEL in 2013 Q2 according to their latest regulatory filings, with 243 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

7% less call options, than puts

Call options by funds: $4.69M | Put options by funds: $5.05M

Holders
243
Holders Change
+243
Holders Change %
–
% of All Funds
7.93%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.1%
New
243
Increased
–
Reduced
–
Closed
–
Calls
$4.69M
Puts
$5.05M
Net Calls
-$363K
Net Calls Change
-$363K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Wellington Management Group
1
Wellington Management Group
Massachusetts
$540M +$467M +8,169,832 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$231M +$200M +3,495,501 New
Bank of New York Mellon
3
Bank of New York Mellon
New York
$223M +$193M +3,371,968 New
Bank of America
4
Bank of America
North Carolina
$199M +$172M +3,008,117 New
BFA
5
BlackRock Fund Advisors
California
$157M +$135M +2,368,461 New
TCM
6
TimesSquare Capital Management
New York
$150M +$129M +2,260,950 New
Federated Hermes
7
Federated Hermes
Pennsylvania
$147M +$127M +2,220,100 New
Ameriprise
8
Ameriprise
Minnesota
$123M +$106M +1,857,879 New
EAM
9
Eagle Asset Management
Florida
$119M +$103M +1,798,109 New
Franklin Resources
10
Franklin Resources
California
$100M +$86.5M +1,512,866 New
Fidelity Investments
11
Fidelity Investments
Massachusetts
$99.4M +$86M +1,503,005 New
ORI
12
Oak Ridge Investments
Illinois
$91.5M +$79.1M +1,382,895 New
BIT
13
BlackRock Institutional Trust
California
$89M +$76.9M +1,345,239 New
HCM
14
Herndon Capital Management
Georgia
$85M +$73.5M +1,284,472 New
State Street
15
State Street
Massachusetts
$80.2M +$69.3M +1,212,443 New
TCIM
16
TIAA CREF Investment Management
New York
$74.9M +$64.7M +1,132,183 New
Invesco
17
Invesco
Georgia
$68.3M +$59.1M +1,032,877 New
Schroder Investment Management Group
18
Schroder Investment Management Group
United Kingdom
$52.8M +$45.6M +798,200 New
UBS AM
19
UBS AM
Illinois
$50.6M +$43.7M +764,595 New
ZCI
20
Zevenbergen Capital Investments
Washington
$41.5M +$35.8M +626,800 New
RIM
21
Rainier Investment Management
Washington
$39.1M +$33.8M +590,860 New
Fidelity International
22
Fidelity International
Bermuda
$33.8M +$29.3M +511,515 New
KI
23
Kalmar Investments
Delaware
$31.4M +$27.2M +475,250 New
T. Rowe Price Associates
24
T. Rowe Price Associates
Maryland
$31.2M +$27M +471,273 New
CCM
25
Consonance Capital Management
New York
$31M +$26.8M +467,943 New
1
2 3 4 5

SLXP Hedge Fund Activity: Q2 2013 in Review

243 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in SALIX PHARMACEUTICALS LTD DEL (SLXP) for Q2 2013, worth a combined $3.96B.

Buyers outnumbered sellers: 243 funds opened new SLXP positions and 0 closed out — a net gain of 243 holders — while 0 added to existing stakes and 0 trimmed.

  • 243 institutional investors held SALIX PHARMACEUTICALS LTD DEL (SLXP) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $3.96B of SALIX PHARMACEUTICALS LTD DEL stock for Q2 2013.
  • 243 funds opened new SALIX PHARMACEUTICALS LTD DEL positions in Q2 2013 and 0 closed out, a net change of +243 holders.

Based on aggregated 13F filings for Q2 2013.